These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

10174 related items for PubMed ID: 1833098

  • 1. Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma.
    Roth AD, Hornicek FJ, Gerstner CG, Kirkwood JM.
    Clin Exp Immunol; 1991 Oct; 86(1):163-72. PubMed ID: 1833098
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interferon-alpha (IFN-alpha) stimulates anti-melanoma cytotoxic T lymphocyte (CTL) generation in mixed lymphocyte tumour cultures (MLTC).
    Palmer KJ, Harries M, Gore ME, Collins MK.
    Clin Exp Immunol; 2000 Mar; 119(3):412-8. PubMed ID: 10691911
    [Abstract] [Full Text] [Related]

  • 5. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).
    Wang P, Vánky F, Klein E.
    Int J Cancer; 1992 Jul 30; 51(6):962-7. PubMed ID: 1386348
    [Abstract] [Full Text] [Related]

  • 6. Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha.
    Young MR, McCloskey G, Wright MA, Pak AS.
    Cancer Immunol Immunother; 1994 Jan 30; 38(1):9-15. PubMed ID: 8299123
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-12 amplifies the M. leprae hsp65-cytotoxic response in the presence of tumour necrosis factor-alpha and interferon-gamma generating CD56+ effector cells: interleukin-4 downregulates this effect.
    Aleman M, De La Barrera S, Fink S, Finiasz M, Farina MH, Pizzariello G, Sasiain MD.
    Scand J Immunol; 2000 Mar 30; 51(3):262-70. PubMed ID: 10736095
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cells.
    Hoon DS, Hayashi Y, Morisaki T, Foshag LJ, Morton DL.
    Cancer Immunol Immunother; 1993 Nov 30; 37(6):378-84. PubMed ID: 8242663
    [Abstract] [Full Text] [Related]

  • 9. Lymphocytes infiltrating ovarian malignant ascites: modulation of IL-2-induced proliferation by IL-4 and of selective increase in CD8+ T cells by TNF-alpha.
    Ioannides CG, Rashed S, Fisk B, Fan D, Itoh K, Freedman RS.
    Lymphokine Cytokine Res; 1991 Aug 30; 10(4):307-15. PubMed ID: 1932375
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
    Zennadi R, Abdel-Wahab Z, Seigler HF, Darrow TL.
    Cell Immunol; 2001 Jun 15; 210(2):96-105. PubMed ID: 11520076
    [Abstract] [Full Text] [Related]

  • 12. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE, Spits H.
    J Immunol; 1984 Jan 15; 132(1):510-9. PubMed ID: 6197458
    [Abstract] [Full Text] [Related]

  • 13. Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class I-restricted cytolytic T-lymphocyte (CTL) clones.
    Wölfel T, Herr W, Coulie P, Schmitt U, Meyer zum Büschenfelde KH, Knuth A.
    Int J Cancer; 1993 Jun 19; 54(4):636-44. PubMed ID: 8514455
    [Abstract] [Full Text] [Related]

  • 14. T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: evidence with a single T cell clone.
    Mazzocchi A, Anichini A, Castelli C, Sensi M, Poli F, Russo C, Parmiani G.
    Cancer Immunol Immunother; 1990 Jun 19; 32(1):13-21. PubMed ID: 2149669
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
    Itoh K, Platsoucas CD, Balch CM.
    J Exp Med; 1988 Oct 01; 168(4):1419-41. PubMed ID: 3262710
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CD8+ tumor-specific Tc cells primed in vivo or in vitro against the BALB/c plasmacytoma ADJ-PC-5 use the same TcR V beta families but display distinct TC1 or TC2 characteristics.
    Becker C, Kölsch E, Pauels HG.
    Immunobiology; 1997 Jun 01; 197(1):16-30. PubMed ID: 9241528
    [Abstract] [Full Text] [Related]

  • 20. [Generation of T cell-mediated antitumor response in vitro by autologous dendritic cells pulsed with tumor lysates in patients with non-small cell lung cancer].
    You J, Yu JP, Ren XB, Wang CL, Zhang P, Zhang XZ.
    Zhonghua Zhong Liu Za Zhi; 2004 Jun 01; 26(6):333-6. PubMed ID: 15312341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 509.